These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4847361)

  • 21. Acanthosis nigricans.
    Holdiness MR
    Arch Dermatol; 1985 May; 121(5):588. PubMed ID: 3888120
    [No Abstract]   [Full Text] [Related]  

  • 22. ACANTHOSIS NIGRICANS-LIKE LESIONS FROM NICOTINIC ACID.
    TROMOVITCH TA; JACOBS PH; KERN S
    Arch Dermatol; 1964 Feb; 89():222-3. PubMed ID: 14081562
    [No Abstract]   [Full Text] [Related]  

  • 23. Palifermin-induced acanthosis nigricans.
    Lane SW; Manoharan S; Mollee PN
    Intern Med J; 2007 Jun; 37(6):417-8. PubMed ID: 17535389
    [No Abstract]   [Full Text] [Related]  

  • 24. Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection.
    Mur A; Seidel V; López-Vílchez MA; Bonet M; Gilaberte M
    Pediatr Infect Dis J; 2005 Aug; 24(8):742-3. PubMed ID: 16094236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatotrophin-induced acanthosis nigricans.
    Downs AM; Kennedy CT
    Br J Dermatol; 1999 Aug; 141(2):390-1. PubMed ID: 10468844
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
    Avogaro P; Capri C; Cazzolato G; Pais M; Trabuio GF
    Atherosclerosis; 1974; 20(2):395-400. PubMed ID: 4369975
    [No Abstract]   [Full Text] [Related]  

  • 27. Acanthosis nigricans in association with congenital adrenal hyperplasia: resolution after treatment. Case report.
    Kurtoğlu S; Atabek ME; Keskin M; Canöz O
    Turk J Pediatr; 2005; 47(2):183-7. PubMed ID: 16052863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acanthosis nigricans with etretinate (Tigason) in a patient with Lawrence-Seip syndrome (generalized lipodystrophy).
    Mørk NJ; Rajka G; Halse J
    Acta Derm Venereol; 1986; 66(2):173-4. PubMed ID: 2424246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
    Orö L
    Lakartidningen; 1970 Dec; 67():Suppl IV:63+. PubMed ID: 5511953
    [No Abstract]   [Full Text] [Related]  

  • 30. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acanthosis nigricans-like lesions after local application of fusidic acid.
    Teknetzis A; Lefaki I; Joannides D; Minas A
    J Am Acad Dermatol; 1993 Mar; 28(3):501-2. PubMed ID: 8445074
    [No Abstract]   [Full Text] [Related]  

  • 32. Acanthosis nigricans during treatment with aripiprazole.
    Manu P; Al-Dhaher Z; Dargani N; Correll CU
    Am J Ther; 2014; 21(3):e90-3. PubMed ID: 23011171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous Insulin-Induced Localized Acanthosis Nigricans: A Rare Injection Site Complication.
    Pal R; Bhattacharjee R; Chatterjee D; Bhadada SK; Bhansali A; Dutta P
    Can J Diabetes; 2020 Apr; 44(3):219-221. PubMed ID: 31619326
    [No Abstract]   [Full Text] [Related]  

  • 34. Acanthosis nigricans in a patient treated with palifermin.
    Lee M; Grassi M
    Cutis; 2010 Sep; 86(3):136-7. PubMed ID: 21049730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acanthosis nigricans--an uncommon cutaneous adverse effect of a common medication: report of two cases.
    Sawatkar GU; Dogra S; Bhadada SK; Kanwar AJ
    Indian J Dermatol Venereol Leprol; 2013; 79(4):553. PubMed ID: 23760338
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical therapy for the syndrome of familial virilization, insulin resistance, and acanthosis nigricans.
    Corenblum B; Baylis BW
    Fertil Steril; 1990 Mar; 53(3):421-5. PubMed ID: 2137793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Etiology of acanthosis nigricans].
    Katzenelson V; Ginzburg A; Sandbank M
    Med Clin (Barc); 1988 Nov; 91(17):671-4. PubMed ID: 3068434
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 39. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.
    Kong AS; Williams RL; Smith M; Sussman AL; Skipper B; Hsi AC; Rhyne RL;
    Ann Fam Med; 2007; 5(3):202-8. PubMed ID: 17548847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acanthosis nigricans following diethylstilbestrol therapy. Occurrence in patients with childhood muscular dystrophy.
    Banuchi SR; Cohen L; Lorincz AL; Morgan J
    Arch Dermatol; 1974 Apr; 109(4):545-6. PubMed ID: 4819110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.